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Neuroendocrine dysfunction is associated with human 
immunodeficiency virus type 1 (HIV-1) among infected men and 
women [1]. Glycoprotein 120 (gp120), the HIV-1 envelope 
protein that is critical for viral infection, also induces 
neurotoxicity and is therefore thought to contribute to the 
pathogenesis of HIV-associated neurological disorder (HAND) 
[2]. However, the mechanisms and degree to which gp120 causes 
neuroendocrine and related behavioral pathology are poorly 
understood. Sex differences in gp120 expression have been 
investigated [3] and our group has observed pregnane steroid 
metabolites to exert neuroprotective effects over other HIV-1 
proteins [4], but it is unknown if this protection extends to actions 
of gp120. We hypothesized that the expression of gp120 in mice 
would promote affective behavioral pathology (e.g. increased 
anxiety- and depression-like behavior) and that fluctuation of 
gonadal steroids (predominantly estrogens and/or progestogens) 
across the female rodent estrous cycle would attenuate these 
effects. Contrary to expectation, gp120 expression decreased 
anxiety-like behavior on a light-dark transition test (with no 
difference in depression-like behavior), but also produced 
neurotoxicity in cell culture. These data may indicate a disruption 
in the neural networks that promote behavioral inhibition. In 
support, other neurotoxic HIV-1 proteins have been observed to 
produce behavioral disinhibition [5]. The neural circuits that may 
be targeted by gp120 to influence affective behavior are the 
subject of future investigation. 
• In vivo, gp120 expression will promote anxiety- and 
depression-like behavior in mice. These effects will be 
ameliorated in female proestrous (high-hormone) mice. 
• In vitro, exposure of gp120 will promote necrosis in 
primary medium spiny neurons.
Animal Subjects: gp120-tansgenic mice [2] were bred in the vivarium at the 
University of Mississippi (University, MS). gp120 is expressed under the 
control of a glial fibrillary acidic protein promoter. Mice were kept in a 
temperature- and humidity-controlled environment on a 12:12 h light:dark 
cycle (lights off at 09:00 h) with ad libitum access to food and water. 
Behavioral Testing: 
Mice were assessed in a behavioral battery of tests in the same order. 
   Open Field       Elevated Plus Maze       Light-Dark       Tail Suspension 
Open Field: A measure of general activity and anxiety. A mouse is 
placed in a the box (brightly-lit center) for 5 min. 
Light Dark Test: A measure of anxiety. Mice are placed in a box divided into 
one well-lit and one dark section and assessed for 5 min. 
Elevated Plus Maze: A measure of anxiety. Mice are place in a elevated cross 
maze with two closed arms and two open arms for 5 min. 
Tail Suspension: A depressive measure. Mice are suspended by the tail and 
immobility/struggling is assessed for 4 min.  
Live/Dead Assay: Medium spiny neurons were grown in co-culture with 
mixed glia cells. All were obtained from C57BL/6N mice as described [4]. 
Cells were exposed to propidium iodide and Hoechst 33342 to determine 
dead and total cell counts, respectively.
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• Male mice made significantly more center entries than 
did diestrous females (Fig. 1A). 
• Diestrous females and males took significantly less time 
to enter the dark side of a light-dark apparatus than did 
proestrus females. In addition, gp120(+)-exposed mice 
took longer to enter the dark side of the apparatus than 
did gp120(−) mice  (Fig. 1B). 
• Males spent less time on the open arms of an elevated 
plus maze than did proestrous or diestrous females (Fig. 
1C). 
• No significant differences in the time spent immobile 
were observed on the tails suspension test (Fig. 1D). 
• X4- or R5-gp120 produced significant necrosis in 
medium spiny neurons after 24- or 48 h (Fig. 2). 
• Neuronal necrosis was greater after 48 hours compared 
to that observed after 24 hours (Fig. 2). 
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←Figure 2. Co-cultured medium spiny neurons 
neurons and mixed glia were obtained from C57BL/6N 
mice. Cells were exposed to media (control), X4-tropic 
gp120 (500 pM), or R5-tropic gp120 (500 pM) proteins 
for 24 or 48 hours.  
✽ significant difference from respective control;  
† significant difference from 24 h time point, p < 0.05. 
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Figure 1. Female mice were in the proestrous or diestrous phase of their estrous cycle. Female and male mice that expressed gp120 
(gp120+) or did not (gp120−) were assessed in a behavioral battery  (n=9/grp). (A): The frequency of entries into the brightly-lit center 
of an open field; (B) The latency to enter the dark-side in the  light-dark transition test; (C) The time spent in the open arms of an 
elevated plus maze; (D) Time spent immobile in a tail suspension test. ‡ indicates significant difference from diestrous females; † 
indicates significant difference from proestrous females; ✽ indicates significant effect of gp120, p < 0.05. 
The present data demonstrate the capacity for 
gp120 exposure to decrease anxiety-like 
behavior in vivo while promoting neurotoxic 
effects in vitro. These seemingly paradoxical 
findings may be the result of a disruption in the 
neural networks that promote behavioral 
inhibition. Thus, future investigations may 
assess prefrontal inhibitory circuitry that may be 
disrupted by gp120 protein, potentially 
contributing to HAND. 
Figure 2 (Inset). 
Representative live/dead 
image form our prior 
work using current 
methodology [4].
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